Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients

被引：7
|
作者：
Berruti, Alfredo [1 ]
Tucci, Marcello
Mosca, Alessandra
Vana, Federica
Ardine, Mara
Dogliotti, Luigi
Angeli, Alberto
Bertoldo, Francesco
机构：
[1] Univ Turin, Oncol Med Azienda Osped San Luigi, Dipartimento Sci Clin & Biol, Orbassano, Italy
[2] Azienda Sanitaria Locale 8, Chiezi, Italy
[3] Univ Verona, Policlin GB Rossi, Dipartimento Sci Biomed & Chirurg, Sez Med D, I-37100 Verona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 11期
关键词：
D O I：
10.1200/JCO.2006.08.7080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1455 / 1456
页数：3
相关论文
共 50 条
  • [41] Changes in Bone Mineral Density During Aromatase Inhibitor Therapy in Post-menopausal Breast Cancer Patients in Japanese
    Sato, T.
    Muto, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S151 - S151
  • [42] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Catherine Van Poznak
    Breast Cancer Research, 12
  • [43] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Van Poznak, Catherine
    BREAST CANCER RESEARCH, 2010, 12 (03):
  • [44] A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
    Hook, Christine
    Chatterjee, Udit
    Sheng, Haiyang
    Zhu, Qianqian
    Robinson, Timothy
    Roh, Janise M.
    Laurent, Cecile A.
    Lee, Catherine
    Delmerico, Jennifer
    Lo, Joan C.
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Kwan, Marilyn L.
    Yao, Song
    NPJ BREAST CANCER, 2024, 10 (01)
  • [45] A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
    Christine Hook
    Udit Chatterjee
    Haiyang Sheng
    Qianqian Zhu
    Timothy Robinson
    Janise M. Roh
    Cecile A. Laurent
    Catherine Lee
    Jennifer Delmerico
    Joan C. Lo
    Christine B. Ambrosone
    Lawrence H. Kushi
    Marilyn L. Kwan
    Song Yao
    npj Breast Cancer, 10
  • [46] Aromatase inhibitors in adjuvant setting in breast cancer
    Spano, JP
    Khayat, D
    Delozier, T
    BULLETIN DU CANCER, 2004, 91 : S239 - S243
  • [47] Aromatase inhibitors as adjuvant therapy for breast cancer
    Maass, N
    Jonat, W
    GYNAKOLOGE, 2003, 36 (02): : 103 - 109
  • [48] Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer
    Montemurro, Filippo
    Aglietta, Massimo
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2566 - 2567
  • [49] Aromatase inhibitors as adjuvant treatment of breast cancer
    Geisler, J
    Lonning, PE
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (01) : 53 - 61
  • [50] BONE-MINERAL DENSITY AFTER ADJUVANT CHEMOTHERAPY FOR PREMENOPAUSAL BREAST-CANCER
    BRUNING, PF
    PIT, MJ
    DEJONGBAKKER, M
    VANDENENDE, A
    HART, A
    VANENK, A
    BRITISH JOURNAL OF CANCER, 1990, 61 (02) : 308 - 310
12345